TAYSHA GENE THERAPIES : LONGER-TERM SAFETY & EFFICACY DATA UPDATE FROM PART A OF REVEAL PHASE 1/2 TRIALS EXPECTED IN H1 2026

Reuters · 6d ago

Please log in to view news